MommaConnect, a mobile health platform (mHealth) based on our evidence-based Mother-Baby Connections (MBC) perinatal mental health program

项目摘要 背景：产后抑郁症（PPD）是最常见的分娩并发症， 妇女，对母亲及其婴儿的健康产生长期不利影响。非裔美国人/黑人（AA/B）女性 患产后抑郁症的可能性是白色女性的两倍。然而，尽管严重的结果，许多AA/B 由于心理健康方面的耻辱感等障碍，母婴二人组得不到专门的心理保健， 医疗保健不公平、儿童保育问题、交通挑战以及难以获得量身定制的专业治疗 到PPD。此外，AA/B妇女对心理健康服务的利用还受到“坚强黑人妇女”的影响 模式（SBW;即，AA/B类妇女认为需要“独立、沉默和自我牺牲”）。一个 需要一个基于证据的、与文化相关的心理健康计划来支持AA/B妇女的需求。 从科学、技术和临床角度来看，MommaConnect在解决特定障碍方面具有新颖性， PPD妇女（包括AA/B母亲）的可获得性、可接受性和可负担性。I期特异性 目标是： 1.与6-8位AA/B女性共同打造MommaConnect mHealth平台内容， PPD我们将利用重点小组与AA/B妇女共同创建MommaConnect平台。 2.评价MommaConnect平台在30名患有PPD的AA/B女性中的可行性， 12周，6名临床医生。 方法：我们的SBIR第一阶段将通过快速支持共同创建和评估 MommaConnect是一种移动的健康应用程序，可提供为期12周的干预，以减少PPD 严重性和改善母婴互动的质量，即，支持健康婴儿的关键机制 发展MommaConnect整合了两种已建立的循证疗法：母婴互动 人际心理治疗（Interpersonal Psychotherapy，IPT）IPT和MBI共享一个人际框架， 强调母亲和婴儿之间重要的人际关系。 影响：本研究的结果可以为进一步开发一种创新的 为产后抑郁症妇女及其婴儿提供围产期心理健康治疗，改善获得心理健康服务的机会， 减少PPD症状，促进婴儿积极的发育结果。

Project Summary Background: Postpartum depression (PPD) is the most common childbirth complication that affects 10-15% of all women, with long-term adverse health outcomes for mothers and their infants. African American/Black (AA/B) women are twice as likely to experience PPD compared to White women. However, despite severe outcomes, many AA/B mother-infant dyads do not receive specialized mental health care due to barriers such as mental health stigma, healthcare inequities, childcare issues, transportation challenges, and poor access to specialized treatment tailored to PPD. Furthermore, AA/B women’s use of mental health services is also influenced by the Strong Black Woman schema (SBW; i.e., AA/B women’s belief in the need to be “independent, self-silencing, and self-sacrificing”). An evidence-based, culturally-relevant mental health program is needed to support the needs of AA/B women. MommaConnect is novel from scientific, technical, and clinical perspectives in addressing specific barriers to accessibility, acceptability, and affordability among women with PPD, including AA/B mothers. Phase I specific aims are to: 1. Co-create the MommaConnect mHealth platform content with 6-8 AA/B women who have experienced PPD. We will leverage focus groups with AA/B women to co-create the MommaConnect platform. 2. Evaluate feasibility of the MommaConnect platform with 30 AA/B women who have experienced PPD for 12 weeks with 6 clinicians. Methods: Our SBIR Phase I will address these barriers by quickly supporting the co-creation and evaluation of the feasibility of MommaConnect, a mobile health application, which delivers a 12-week intervention to reduce PPD severity and improve the quality of mother-infant interaction, i.e., the critical mechanism that supports healthy infant development. MommaConnect integrates two established evidence-based therapies: Mother-Baby Interaction Therapy (MBI) and Interpersonal Psychotherapy (IPT). IPT and MBI share an interpersonal framework that emphasizes the critical interpersonal relationship between mothers and their infants. Implications: The outcomes from this study can inform further development of an innovative model of delivery of perinatal mental health treatment for women with PPD and their infants, improve access to mental health services, reduce PPD symptoms, and promote positive infant developmental outcomes.